학술논문

Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, July 2023, 24(7):783-797)
Subject
Language
English
ISSN
14745488
14702045